These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23879722)

  • 1. Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review.
    Athyros VG; Katsiki N; Doumas M; Karagiannis A; Mikhailidis DP
    Curr Med Res Opin; 2013 Oct; 29(10):1263-74. PubMed ID: 23879722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking and smoking cessation -- the relationship between cardiovascular disease and lipoprotein metabolism: a review.
    Chelland Campbell S; Moffatt RJ; Stamford BA
    Atherosclerosis; 2008 Dec; 201(2):225-35. PubMed ID: 18565528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking and vascular risk: are all forms of smoking harmful to all types of vascular disease?
    Katsiki N; Papadopoulou SK; Fachantidou AI; Mikhailidis DP
    Public Health; 2013 May; 127(5):435-41. PubMed ID: 23453194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone administration decreases cardiovascular disease risk factors in insulin-resistant smokers.
    Abbasi F; Farin HM; Lamendola C; McGraw L; McLaughlin T; Reaven GM
    Metabolism; 2008 Aug; 57(8):1108-14. PubMed ID: 18640389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the health benefits of smoking cessation in Japan.
    Avila-Tang E; Apelberg BJ; Yamaguchi N; Katanoda K; Sobue T; Samet JM
    Tob Control; 2009 Feb; 18(1):10-7. PubMed ID: 18728096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of smoking cessation with focus on cardiovascular and respiratory comorbidities.
    Godtfredsen NS; Prescott E
    Clin Respir J; 2011 Oct; 5(4):187-94. PubMed ID: 21689381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathophysiological effects of active and passive smoking on the cardiovascular system.
    Taylor BV; Oudit GY; Kalman PG; Liu P
    Can J Cardiol; 1998 Sep; 14(9):1129-39. PubMed ID: 9779018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Women and smoking].
    Schmeiser-Rieder A; Schoberberger R; Kunze M
    Wien Med Wochenschr; 1995; 145(4):73-6. PubMed ID: 7778322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease.
    Halvorsen B; Lund Sagen E; Ueland T; Aukrust P; Tonstad S
    Scand J Clin Lab Invest; 2007; 67(6):604-11. PubMed ID: 17852807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible involvement of tobacco-derived advanced glycation end products (AGEs) in an increased risk for developing cancers and cardiovascular disease in former smokers.
    Yamagishi S; Matsui T; Nakamura K
    Med Hypotheses; 2008 Aug; 71(2):259-61. PubMed ID: 18448262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey.
    Bakhru A; Erlinger TP
    PLoS Med; 2005 Jun; 2(6):e160. PubMed ID: 15974805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking cessation in chronic obstructive pulmonary disease.
    Tashkin DP; Murray RP
    Respir Med; 2009 Jul; 103(7):963-74. PubMed ID: 19285850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the measures of pulsatile arterial function between asymptomatic younger adult smokers and former smokers: the Bogalusa Heart Study.
    Li H; Srinivasan SR; Berenson GS
    Am J Hypertens; 2006 Sep; 19(9):897-901. PubMed ID: 16942930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.
    Wannamethee SG; Lowe GD; Shaper AG; Rumley A; Lennon L; Whincup PH
    Eur Heart J; 2005 Sep; 26(17):1765-73. PubMed ID: 15817606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Health damage caused by smoking].
    Deckers JW; van Berkel TF
    Ned Tijdschr Tandheelkd; 1999 Nov; 106(11):400-3. PubMed ID: 11930405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital- and clinic-based smoking cessation interventions for smokers with cardiovascular disease.
    Thomson CC; Rigotti NA
    Prog Cardiovasc Dis; 2003; 45(6):459-79. PubMed ID: 12800128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking, smoking cessation, and understanding of the role of multiple cardiac risk factors among the urban poor.
    Hyman DJ; Simons-Morton DG; Dunn JK; Ho K
    Prev Med; 1996; 25(6):653-9. PubMed ID: 8936566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is weak association between cigarette smoking and cardiovascular disease mortality observed in Japan explained by low total cholesterol? NIPPON DATA80.
    Hozawa A; Okamura T; Kadowaki T; Murakami Y; Nakamura K; Hayakawa T; Kita Y; Nakamura Y; Okayama A;
    Int J Epidemiol; 2007 Oct; 36(5):1060-7. PubMed ID: 17846054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere length is a biomarker of cumulative oxidative stress, biologic age, and an independent predictor of survival and therapeutic treatment requirement associated with smoking behavior.
    Babizhayev MA; Savel'yeva EL; Moskvina SN; Yegorov YE
    Am J Ther; 2011 Nov; 18(6):e209-26. PubMed ID: 20228673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette smoking, smoking cessation, and diabetes.
    Tonstad S
    Diabetes Res Clin Pract; 2009 Jul; 85(1):4-13. PubMed ID: 19427049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.